SE503469C2 - Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol - Google Patents

Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol

Info

Publication number
SE503469C2
SE503469C2 SE8703972A SE8703972A SE503469C2 SE 503469 C2 SE503469 C2 SE 503469C2 SE 8703972 A SE8703972 A SE 8703972A SE 8703972 A SE8703972 A SE 8703972A SE 503469 C2 SE503469 C2 SE 503469C2
Authority
SE
Sweden
Prior art keywords
eye drops
agent
viscosity
isotonic
salt
Prior art date
Application number
SE8703972A
Other languages
English (en)
Swedish (sv)
Other versions
SE8703972D0 (sv
SE8703972L (sv
Inventor
Dikstein Shabtay
Original Assignee
Res & Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11057204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE503469(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res & Dev Co Ltd filed Critical Res & Dev Co Ltd
Publication of SE8703972D0 publication Critical patent/SE8703972D0/xx
Publication of SE8703972L publication Critical patent/SE8703972L/xx
Publication of SE503469C2 publication Critical patent/SE503469C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8703972A 1986-10-14 1987-10-13 Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol SE503469C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL80298A IL80298A (en) 1986-10-14 1986-10-14 Eye drops

Publications (3)

Publication Number Publication Date
SE8703972D0 SE8703972D0 (sv) 1987-10-13
SE8703972L SE8703972L (sv) 1988-04-15
SE503469C2 true SE503469C2 (sv) 1996-06-24

Family

ID=11057204

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703972A SE503469C2 (sv) 1986-10-14 1987-10-13 Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol

Country Status (8)

Country Link
US (1) US5106615A (it)
CA (1) CA1311418C (it)
DE (1) DE3734835C2 (it)
FR (1) FR2604906B1 (it)
GB (1) GB2196255B (it)
IL (1) IL80298A (it)
IT (1) IT1211852B (it)
SE (1) SE503469C2 (it)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323522A4 (en) * 1987-07-07 1989-08-30 Santen Pharmaceutical Co Ltd ARTIFICIAL TEAR.
JPH05503527A (ja) * 1990-02-22 1993-06-10 マクノート・ピーティーワイ・リミテッド 人工涙液
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
DE4225489A1 (de) * 1992-07-30 1994-02-03 Michael Prof Dr Rer Na Dittgen Verfahren zur Herstellung bioadhäsiver Augentropfen
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
US5645827A (en) * 1992-09-30 1997-07-08 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
FR2717691B1 (fr) * 1994-03-22 1998-02-13 Europhta Laboratoire Nouveaux gels ophtalmiques et leur procédé d'obtention.
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
IT1274984B (it) * 1994-12-09 1997-07-29 Technopharma Sa Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
WO1997014785A2 (en) * 1995-10-19 1997-04-24 Advanced Reproduction Technologies, Inc. Methods and compositions to improve germ cell and embryo survival and function
IT1277707B1 (it) 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
WO1997045102A1 (en) * 1996-05-31 1997-12-04 Schwadrohn, Gérard Novel therapeutic use of ophthalmic gels
US5840046A (en) * 1996-06-21 1998-11-24 Medtronic, Inc. Guidewire having hydrophilic coating
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6277365B1 (en) 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
CN1175904C (zh) * 1998-05-15 2004-11-17 若素制药株式会社 抗炎滴眼剂
ES2255987T3 (es) 1999-03-01 2006-07-16 Milcin Therapeutics Llc Preparaciones oftalmicas conteniendo mucina.
US6703039B2 (en) 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
WO2002049611A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic lubricating solution adapted for use in lasik surgery
WO2002049610A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US6656460B2 (en) 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
WO2003059263A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions.
PL211494B1 (pl) 2001-12-21 2012-05-31 Alcon Zastosowanie syntetycznych, nieorganicznych nanocząstek jako nośników dla leków i kompozycja farmaceutyczna do oczu lub uszu
MXPA05000186A (es) * 2002-07-03 2005-08-17 Pericor Science Inc Composiciones de acido hialuronico y metodos de uso.
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
EP2113246B1 (en) * 2003-08-07 2016-06-22 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
CN102120031B (zh) 2003-08-07 2012-12-05 希尔洛有限公司 用于加速伤口愈合的药物组合物和方法
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
WO2005072701A1 (en) 2004-01-20 2005-08-11 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
EP1720518B1 (en) * 2004-02-26 2009-08-12 Bausch & Lomb Incorporated Alginate viscoelastic composition, method of use and package
US7842382B2 (en) * 2004-03-11 2010-11-30 Knauf Insulation Gmbh Binder compositions and associated methods
US8147865B2 (en) * 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
EP1802357B2 (en) * 2004-10-01 2013-09-18 Menicon Singapore Pte Ltd. Method for sterilising contact lens with package solution
JP2008516071A (ja) * 2004-10-13 2008-05-15 クナーフ インシュレーション ゲーエムベーハー ポリエステル結合性組成物
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
DE602006006424D1 (de) * 2005-02-09 2009-06-04 Safilens S R L Ackung zur aufbewahrung und pflege einer kontaktlinse
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
IL168603A (en) † 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
US10183076B2 (en) 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
KR102212329B1 (ko) * 2005-07-26 2021-02-08 크나우프 인설레이션, 인크. 접착제 및 이들로 만들어진 물질
CA2625674C (en) * 2005-08-29 2015-04-14 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
FR2895907B1 (fr) 2006-01-06 2012-06-01 Anteis Sa Gel viscoelastique a usage dermatologique
JP5179381B2 (ja) 2006-02-17 2013-04-10 ノバルティス アーゲー ヒドロゲルコンタクトレンズの滅菌方法
CN101668713B (zh) 2007-01-25 2012-11-07 可耐福保温材料有限公司 矿物纤维板
DK2826903T3 (da) * 2007-01-25 2023-06-06 Knauf Insulation Fremgangsmåde til fremstilling af mineralfiberisoleringsprodukt
US20100084598A1 (en) * 2007-01-25 2010-04-08 Roger Jackson Mineral fibre insulation
BRPI0721232B1 (pt) 2007-01-25 2023-01-24 Knauf Insulation Limited Placa de madeira compósita
EP3795546A1 (en) 2007-01-25 2021-03-24 Knauf Insulation GmbH Binders and materials made therewith
CA2683706A1 (en) 2007-04-13 2008-10-23 Knauf Insulation Gmbh Composite maillard-resole binders
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
US10028976B2 (en) 2007-07-02 2018-07-24 Aptissen Sa Injectable formulation of natural polysaccharide and polyol for treatment of osteoarthritis
CN101802031B (zh) * 2007-07-05 2012-10-17 可耐福保温材料有限公司 羟基单羧酸基梅拉德粘结剂
US20100310542A1 (en) * 2007-07-30 2010-12-09 Healor Ltd. Pharmaceutical Compositions for treating wouds and related methods
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
GB0715100D0 (en) 2007-08-03 2007-09-12 Knauf Insulation Ltd Binders
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
US20170354624A1 (en) * 2007-11-14 2017-12-14 Resdevco Research And Development Co. Ltd. Topical compositions for treatment of skin irritation
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
CA2770396A1 (en) 2009-08-07 2011-02-10 Knauf Insulation Molasses binder
AU2010326099B2 (en) 2009-12-03 2013-03-07 Novartis Ag Carboxyvinyl polymer-container nanoparticle suspensions
EP2523677A2 (en) 2010-01-11 2012-11-21 Healor Ltd. Method for treatment of inflammatory disease and disorder
MX339649B (es) 2010-05-07 2016-06-02 Knauf Insulation * Aglutinantes de carbohidrato y materiales hechos con los mismos.
AU2011249759B2 (en) 2010-05-07 2014-11-06 Knauf Insulation Carbohydrate polyamine binders and materials made therewith
CA2801546C (en) 2010-06-07 2018-07-10 Knauf Insulation Fiber products having temperature control additives
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
WO2012063237A2 (en) 2010-11-08 2012-05-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
IL212725A (en) 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
CA2834816C (en) 2011-05-07 2020-05-12 Knauf Insulation Liquid high solids binder composition
GB201206193D0 (en) 2012-04-05 2012-05-23 Knauf Insulation Ltd Binders and associated products
GB201214734D0 (en) 2012-08-17 2012-10-03 Knauf Insulation Ltd Wood board and process for its production
WO2014086777A2 (en) 2012-12-05 2014-06-12 Knauf Insulation Binder
JP6215354B2 (ja) 2013-01-23 2017-10-18 セムヌール ファーマシューティカルズ， インコーポレイテッド 不溶性コルチコステロイドおよび可溶性コルチコステロイドを含む医薬処方物
US20140378401A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
US11401204B2 (en) 2014-02-07 2022-08-02 Knauf Insulation, Inc. Uncured articles with improved shelf-life
GB201408909D0 (en) 2014-05-20 2014-07-02 Knauf Insulation Ltd Binders
TWI674899B (zh) * 2015-01-21 2019-10-21 美商桑紐爾製藥公司 醫藥配方
GB201517867D0 (en) 2015-10-09 2015-11-25 Knauf Insulation Ltd Wood particle boards
GB201610063D0 (en) 2016-06-09 2016-07-27 Knauf Insulation Ltd Binders
GB201701569D0 (en) 2017-01-31 2017-03-15 Knauf Insulation Ltd Improved binder compositions and uses thereof
JP7258778B2 (ja) 2017-03-05 2023-04-17 レスデブコ リサーチ アンド ディベロップメント カンパニー リミテッド 感染によるものではない刺激の治療のための点眼剤
GB201804907D0 (en) 2018-03-27 2018-05-09 Knauf Insulation Ltd Composite products
GB201804908D0 (en) 2018-03-27 2018-05-09 Knauf Insulation Ltd Binder compositions and uses thereof
WO2021156856A1 (en) 2020-02-03 2021-08-12 Resdevco Research And Development Co. Ltd. Topical opthalmological composition containing hyaluronate and taurine having non-newtonian rheological properties

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB904797A (en) * 1959-12-23 1962-08-29 Boots Pure Drug Co Ltd Ophthalmic medicaments comprising phenanthridinium salts
GB1044449A (en) * 1965-05-18 1966-09-28 Boots Pure Drug Co Ltd Improvements in ophthalmic preparations
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
CS261206B2 (en) * 1980-03-21 1989-01-12 Wellcome Found Isotonization and stabilization agent
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
GB2090013B (en) * 1980-12-18 1984-04-11 Smith & Nephew Ass Soft contact lens sterilising solution
JPS5857319A (ja) * 1981-09-30 1983-04-05 Green Cross Corp:The 高粘性ヒアルロン酸製剤
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
EP0145710A1 (en) * 1983-05-25 1985-06-26 Alcon Laboratories, Inc. Ophthalmic solution
EP0145714A1 (en) * 1983-05-25 1985-06-26 Alcon Laboratories, Inc. Ophthalmic gel
PH21406A (en) * 1985-04-19 1987-10-15 Ciba Geigy Ag Ophthalmic solution and methods for improving the comfort and safety of contact lenses
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate

Also Published As

Publication number Publication date
GB8724112D0 (en) 1987-11-18
DE3734835A1 (de) 1988-06-01
SE8703972D0 (sv) 1987-10-13
FR2604906A1 (fr) 1988-04-15
US5106615A (en) 1992-04-21
CA1311418C (en) 1992-12-15
IL80298A (en) 1993-01-31
IT1211852B (it) 1989-11-03
GB2196255B (en) 1991-05-15
DE3734835C2 (de) 1997-07-17
FR2604906B1 (fr) 1992-02-07
GB2196255A (en) 1988-04-27
IT8748495A0 (it) 1987-10-13
IL80298A0 (en) 1987-01-30
SE8703972L (sv) 1988-04-15

Similar Documents

Publication Publication Date Title
SE503469C2 (sv) Isotona fuktande ögondroppar innehållande organiskt fuktmedel såsom glycerol eller sorbitol
US9668997B2 (en) Ophthalmic compositions and methods for treating eyes
US4409205A (en) Ophthalmic solution
CA2675601C (en) Ophthalmic compositions containing a synergistic combination of three polymers
DE60204142T2 (de) Zubereitungen mit olopatadin zur topischen anwendung
US9119827B2 (en) Ophthalmic composition
DE2708152A1 (de) Pharmazeutisches traegermaterial und dessen verwendung
Maichuk Ophthalmic drug inserts.
JPH11335301A (ja) 眼科用製剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
Palmer et al. Tear film, pharmacology of eye drops, and toxicity
WO2000030609A1 (en) Aqueous ophthalmic formulations comprising chitosan
KR102268002B1 (ko) 효과 지속성 점안제 조성물
EP1312380B1 (en) Aseptics
JP4524538B2 (ja) 眼科用組成物
WO2022113970A1 (ja) 涙液層破壊時間短縮型ドライアイ治療剤および該治療剤を含む点眼剤
CN100362991C (zh) 一种眼科用药物组合物
US5662919A (en) Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
JP2023038930A (ja) 眼表面薬物滞留化剤およびこれを含む点眼剤、並びに、これらの剤を用いた眼表面薬物滞留方法および眼科疾患治療方法
JP2000281563A (ja) 眼科用液剤

Legal Events

Date Code Title Description
NUG Patent has lapsed